- Mass General Brigham nurses end walkout: 5 things to know
- Thomas Jefferson University to open 2nd regional medical school campus
- Experity acquires Exdion Healthcare in AI revenue cycle push
- FDA approves 1st on-body cancer drug
- The title CIOs actually want
- The 52 rural emergency hospitals by state
- Virginia system expands rehab care with new hospital
- Ex-ransomware negotiator gets 70 months for BlackCat healthcare attacks
- Minnesota AG secures refunds for patients of dental practice that closed without notice
- 2nd US citizen tests positive for Ebola: 3 outbreak updates
- New Florida ASC expands orthopedic offerings
- Anthropic’s Claude now handles healthcare claims, care management
- MSO acquires 2 physician-owned practices
- Physician among charged in $20M kickback, unnecessary prescription scheme
- Reducing orthopedic coding denials with AI — 4 takeaways
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- 15 states sue US Education Department over mental health cuts
- 23 new behavioral health study findings to know
- Illinois grows certified recovery support workforce 335% since 2022
- New Mexico awards $24.5M for behavioral health expansion
- 38 behavioral health executive moves to know
- Payers are pushing top anesthesiologists out of the insurance model
- Virginia’s largest dental group adds Overjet AI platform
- My Community Dental Centers appoints chief people officer
- Former Illinois dental employee pleads guilty to stealing more than $500K from practice
- CMS’ 2027 rules: Why some specialties are ‘on the outside looking in’
- U of Maryland appoints interim dental school dean
- CMS’ ASC rule: Gains for some, cuts for others
- What leaders need to know about rising mental health leave
- Colorado university closes dental clinic abruptly
- Principal to acquire Beam Benefits, dental provider serving 25,000 businesses
- CMS’ next payment move puts spine ASCs in focus
- The functions ASC leaders won’t hand off
- Washington’s noncompete ban: What healthcare employers need to know
- Doctors want wearable data but healthcare isn't ready for it, AMA survey finds
- MaineHealth launches psychiatric nurse practitioner, physician associate fellowship
- California completes statewide behavioral health shift: 3 things to know
- 3 DSOs making headlines
- SALT Dental Partners adds 14-office North Carolina practice
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- Aspen Dental targets fast-growing Georgia city for new practice
- Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings
- South Carolina cites behavioral health facility over missing correction plan
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- Senators urge Defense Department to expand autism therapy coverage under Tricare
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Beyond Benchmarks: Why Trust Must Be Built into Clinical AI Infrastructure
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- HHS calls on hospitals to sign 'Make Hospital Food Healthier Pledge'
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- Weekly Rundown: Surgical Safety Technologies rebrands to Aimbient; UC San Diego launches applied health intelligence institute
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- How Lee Health Turned Language Access into a Strategic Clinical Asset
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- Decision readiness is the next AI advantage
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Accountability Is Key to Medicaid's Home Care Future
- Clinical Success Is No Longer One Number
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- 9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- FDA Lets 20 ZYN Nicotine Pouches Claim Lower Risk Than Cigarettes; Critics Warn Of Danger
- Ultra-Processed Foods Linked To Brain Differences In Young Children
- Prompt Responses From Mom Might Lower A Baby's Risk Of Childhood Mental Health Problems
- Rehab Program Helps Lift Long COVID 'Brain Fog'
- Why Are You Right- Or Left-Handed? Experiments Suggest Surprisingly Simple Explanation
- Rural Americans More Likely To View Cancer As A Death Sentence, Poll Finds
- Regulatory tracker: NICE urges against future Lumakras reimbursement in UK
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
Michigan healthcare freedom community forum
Controlled substances are about to hit public debate platforms, as is abortion.
As a commissioned officer of the U.S. Public Health Service Commissioned Corps, one of the eight uniformed services of the United States, and by law holding the rank of vice admiral, the Surgeon General of the United States swears an oath to support the Constitution. (Strike one.)
Past surgeons general have come from all political stripes, with divergent allegiance to inherent rights to life, liberty, and property. (Strike two.)
The ERLC Letter is reproduced mid-article.
EXCLUSIVE: Why Largest Protestant Denomination Opposes Trump’s Surgeon General Pick
Elizabeth Troutman Mitchell | April 06, 2026
FIRST ON THE DAILY SIGNAL—The Southern Baptist Convention’s public policy arm opposes President Donald Trump’s nominee for surgeon general, according to a letter obtained by The Daily Signal.
The Ethics and Religious Liberty Commission, the public policy arm of the SBC, wrote a letter to the Senate Health, Education, Labor, and Pensions Committee expressing “deep concern” over the nomination of Dr. Casey Means for surgeon general.
“Dr. Means’ displayed convictions raise a number of concerns for us as Southern Baptists,” ERLC interim President Gary Hollingsworth wrote.
Trump told The Daily Signal last week that withdrawing Means’ nomination amid opposition in the Senate was a possibility. However, White House press secretary Karoline Leavitt later said that “the president stands by her and the Senate should move to quickly confirm Dr. Means as our next surgeon general without further delay.”
The SBC is primarily concerned about Means’ stance on abortion.
“First, as the Bible teaches, Southern Baptists affirm the full dignity of every human being and believe that every life is worthy of protection and celebration,” Hollingsworth wrote. “We believe life begins at conception and that all forms of abortion deny precious preborn human beings of their very lives.”
“Dr. Means has repeatedly opposed these positions and supported abortion,” he continued.
The letter highlighted Means’ confirmation hearing, in which she “skirted questions” about the chemical abortion pill mifepristone. She declined to answer a question about whether mifepristone should only be prescribed after an in-person doctor visit.
“The question of whether it should be an in-person visit is out of the purview of the surgeon general’s office,” Means said, “but I do believe that every patient needs to have a very thorough conversation with their doctor before taking any medication.”
“I think that every medication has risks and benefits,” she added. “I think that all patients need to have a thorough conversation with their doctor and have true informed consent before taking any medication.”
However, Means did take a firm stance on the birth control pill, saying it is prescribed “like candy” and reflects a “disrespect of things that create life.”
The Southern Baptist Convention found it “alarming that the candidate for our nation’s top public health official is clearly noncommittal on such a powerful drug, a drug that harms women and robs innocent children of their very lives.”
The denomination also said that Means’ “blatant flaunting of prior illicit drug use is reason for alarm,” citing her “ongoing experimentation with psilocybin.”
In her book, “Good Energy,” Means recommended that readers who “feel called” should consider using psilocybin, an illegal psychedelic drug.
“Those who seek to lead others in pursuit of health and wellness would not ignore the lack of serious, evidence-based clinical data on psilocybin use,” Hollingsworth wrote. “Doing so is contrary to the protocols of the office she seeks.”
The SBC concluded that Means is “not qualified to serve as our country’s next surgeon general.”
“Should her nomination come up for a vote in committee, we urge you, with abundant cause for medical, moral, and legal concern, to oppose Dr. Means’ nomination,” Hollingsworth wrote to senators.
The SBC's opposition to Dr. Casey Means reeks of Big Pharma instigation. Read her opening statement before the U.S. Senate Committee on Health, Education, Labor and Pensions at:
https://www.help.senate.gov/imo/media/doc/a9bb7a90-b8ce-e420-d906-7b3c4d8b63f8/Means%20Testimony.pdf
Her complete 53 minutes of testimony and responses to Senators' questions are preserved at:
https://www.youtube.com/watch?v=Qk0Vysk6ezA
Dr. Means is clearly hostile to vaccines and birth control pills. There is simply no reason to assume that she is a mifepristone enthusiast. Her muted response appears to be an effort to keep the confirmation hearing from going off the rails.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























